Ayatris, Inc.
About Ayatris, Inc.
Ayatris Inc. is a Maryland-based biotechnology company developing advanced organoid and organ-on-chip technologies for drug discovery, disease modeling, and precision medicine. Through its proprietary and licensed technologies, Ayatris is building scalable, physiologically relevant platforms that help researchers and industry partners accelerate therapeutic development while enabling more human-relevant approaches to biomedical research. The company is headquartered in Frederick, Maryland. Supported by the TEDCO Equitech Growth Fund, Ayatris is building an integrated research infrastructure that combines organoid science, organ-on-chip technologies, advanced imaging, and translational research.
- ๐ Ayatris Awarded TEDCO Grant for Organ-on-Chip Infrastructure
- ๐ TEDCO Announces Awarding $4.3 Million Across Nine Equitech Growth Fund Awardees - MD Clean Energy
- ๐ Sabra Health Care - 2026 Company Profile, Team, Funding & Financials - Tracxn
- ๐ Calvary Health Care - 2026 Company Profile & Funding - Tracxn
- ๐ Central Florida Health Care - 2026 Company Profile, Funding & Competitors - Tracxn
Investors
Not disclosed in the source filing. Form D filings do not list investors โ StreetZero surfaces them from news where available.
Key highlights
- Awarded $1,000,000 TEDCO Equitech Growth Fund grant for organ-on-chip infrastructure
- Headquartered in Frederick, Maryland and focused on organoid technologies
- Building platforms for drug discovery, disease modeling, and precision medicine
- Combining organoid science with advanced imaging and translational research
Ask StreetZero about Ayatris, Inc.
Put our AI to work on this deal.
Similar companies
Other Other Health Care deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account